drugset / Trial / NCT05300841
The Effect of Pretreatment With Dydrogesterone Vs Combined Estradiol Valerate and Dydrogestrone on Clinical Pregnancy Outcome of ICSI in PCOS Patients"
RandomizedParallel-groupOpen-labelTreatment
Summary
To analyze the effect of pretreatment with dydrogesterone vs combined estradiol valerate and dydrogesterone on embryologic parameters, chemical and clinical pregnancy rates of ICSI in women with PCOS.
Timeline
- Start
- 2022-05-01
- Primary completion
- 2023-04-01
- Completion
- 2023-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dydrogesterone | Other / unclassified | 10 mg | Oral |
| Comparator | Dydrogesterone | Other / unclassified | 20 mg | Oral |
| Comparator | estradiol valerate | Unknown | 2 mg | Oral |